A5028960807- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
- Renal Transplantation Outcomes and Treatments
- Parathyroid Disorders and Treatments
- Central Venous Catheters and Hemodialysis
- Renal Diseases and Glomerulopathies
- Organ Donation and Transplantation
- Pharmacological Effects and Toxicity Studies
- Acute Kidney Injury Research
- Renal and Vascular Pathologies
- Magnesium in Health and Disease
- Aluminum toxicity and tolerance in plants and animals
- Pregnancy and Medication Impact
- Organ Transplantation Techniques and Outcomes
- Renal function and acid-base balance
- Muscle and Compartmental Disorders
- Vasculitis and related conditions
- Health Systems, Economic Evaluations, Quality of Life
- Neurological and metabolic disorders
- Diabetes Treatment and Management
- Bone health and treatments
- Genetic and Kidney Cyst Diseases
- Body Composition Measurement Techniques
- Vascular Procedures and Complications
- Healthcare Policy and Management
Zealand University Hospital
2013-2024
University of Copenhagen
2011-2023
Roskilde Sygehus
1982-2023
Herlev Hospital
2008-2020
National Cancer Registry
2019
Kidney Health Australia
2019
Zhaotong University
2019
Copenhagen University Hospital
2005-2015
Creative Commons
2015
Odense University Hospital
2013-2015
Nephrogenic systemic fibrosis is a new, rare disease of unknown cause that affects patients with renal failure. Single cases led to the suspicion causative role gadodiamide used for magnetic resonance imaging. This study therefore reviewed all authors' confirmed nephrogenic (n = 13) respect clinical characteristics, exposure, and subsequent course. It was found had been exposed before development fibrosis. The delay from exposure first sign 2 75 d (median 25 d). Odds ratio acquiring when...
This article summarizes the ERA-EDTA Registry's 2016 Annual Report, by describing epidemiology of renal replacement therapy (RRT) for end-stage disease (ESRD) in within 36 countries.In 2017 and 2018, Registry received data on patients undergoing RRT ESRD from 52 national or regional registries. In all, 32 registries provided individual patient 20 aggregated data. The incidence prevalence survival probabilities these were determined.In 2016, was 121 per million population (pmp), ranging 29...
Congenital anomalies of the kidney and urinary tract (CAKUT) are leading cause ESRD in children, but proportion patients with individual CAKUT entities progressing to during adulthood their long-term clinical outcomes unknown. This study assessed age at onset renal replacement therapy (RRT) patient graft survival across entire range.Patients were compared age-matched who undergoing RRT for other disorders on basis data from European Renal Association-European Dialysis Transplant Association...
Autosomal dominant polycystic kidney disease (ADPKD) is the fourth most common renal requiring replacement therapy (RRT). Still, there are few epidemiological data on prevalence of, and survival RRT for ADPKD. This study used from ERA-EDTA Registry in 12 European countries with 208 million inhabitants. We studied four 5-year periods (1991–2010). Survival analysis was performed by Kaplan–Meier method Cox proportional hazards regression. From first to last period, of ADPKD increased 56.8 91.1...
Abstract Background Chronic kidney disease (CKD) is a global challenge. CKD prevalence estimation central to management strategies and prevention. It necessary predict end stage (ESKD) and, subsequently, the burden for healthcare systems. In this study we characterize 3–5 incidence in cohort covering majority of Region Southern Denmark investigate individuals’ demographic, socioeconomic, comorbidity status. Methods We used data from Kidney Disease Cohort (KidDiCo) combining laboratory with...
Background. The influence of dialysis modality on prognosis is controversial. In the absence randomized trials, epidemiological investigations present best method for studying problem.
Nephrogenic systemic fibrosis may be caused by gadolinium (Gd)-containing magnetic resonance imaging contrast agents. Most reported cases were associated with one particular agent, gadodiamide. Yet, unidentified cofactors might explain why only a minority of renal failure patients exposed to gadodiamide develop nephrogenic fibrosis.We conducted case-control study 19 histologically verified and sex- age-matched controls. All subjects had chronic when Clinical, biochemical pharmacological data...
Abstract. One thousand and ten patient years of oral anticoagulant therapy with vitamin‐K‐antagonists were reviewed regard to major bleeding complications. The incidence that necessitated hospital admission was 2.7% per year (95% confidence limits, 1.7–3.7%). source the alimentary tract, whereas no cases intracranial found. Various factors potential effects on risk evaluated by multivariate statistical analysis, following independent identified: age > 75 hypertension increased 10.5% 4.5%,...
Background. Recent studies have indicated a stabilization in the incidence rates of renal replacement therapy (RRT) for end-stage disease (ESRD) number European countries. The aim this study was to provide an update on incidence, prevalence and outcomes RRT Europe over past decade. Methods. Nineteen national or regional registries with registry data from 1997 2006 participated study. Incidence trends were analysed Poisson Joinpoint regression. Cox regression methods used examine patient...
Diabetes mellitus is becoming increasingly prevalent and considered a rapidly growing concern for healthcare systems.Besides the cardiovascular complications, diabetes associated with chronic kidney disease (CKD).CKD in patients can be caused by true diabetic nephropathy, but also indirectly diabetes, e.g.due to polyneuropathic bladder dysfunction, increased incidence of relapsing urinary tract infections or macrovascular angiopathy.However, many who develop CKD due cause other than will may...
This study examines the time trends in incidence, prevalence, patient and kidney allograft survival causes of death (COD) patients receiving renal replacement therapy (RRT) Europe.Eighteen national or regional registries providing data to European Renal Association-European Dialysis Transplant Association Registry between 1998 2011 were included. Incidence prevalence 2001 studied with Joinpoint Poisson regression. Patient COD analysed using Kaplan-Meier competing risk methods Cox...
Although women have a survival advantage in the general population, on dialysis similar mortality to men. We hypothesized that this paired risk during may be explained by relative excess of cardiovascular-related women.We compared 5-year age-stratified cardiovascular and noncardiovascular rates, risks, hazard ratios European cohort incident adult patients (European Renal Association-European Dialysis Transplant Association [ERA-EDTA] Registry) with population (Eurostat). Cause death was...
This article summarizes the 2012 European Renal Association-European Dialysis and Transplant Association Registry Annual Report (available at www.era-edta-reg.org) with a specific focus on older patients (defined as ≥65 years).Data provided by 45 national or regional renal registries in 30 countries Europe bordering Mediterranean Sea were used. Individual patient level data received from 31 registries, whereas 14 contributed an aggregated form. The incidence, prevalence survival...
Infections and malignancies are the most common non-cardiovascular causes of death in patients on chronic renal replacement therapy (RRT). Here, we aimed to quantify mortality risk attributed infections dialysis kidney transplant recipients when compared with general population by age group sex.We followed 168 156 included ERA-EDTA registry who started RRT 1993-2007 until 1 January 2012. Age- cause-specific rates per 1000 person-years (py) rate ratios (MRRs) European (WHO) were calculated....
Background: This article summarizes the European Renal Association - Dialysis and Transplant Registry's 2014 annual report. It describes epidemiology of renal replacement therapy (RRT) for end-stage disease (ESRD) in within 35 countries. Methods: In 2016, ERA-EDTA Registry received data on patients who where undergoing RRT ESRD, from 51 national or regional registries. Thirty-two registries provided individual patient level 19 aggregated data. The incidence, prevalence survival probabilities...
This article provides a summary of the 2013 European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report (available at http://www.era-edta-reg.org), with focus on patients diabetes mellitus (DM) as cause end-stage renal disease (ESRD). In 2015, ERA-EDTA received data replacement therapy (RRT) for ESRD from 49 national or regional registries in 34 countries Europe bordering Mediterranean Sea. Individual patient were provided by 31 registries, while...
Background. Information on demographics and survival of patients starting renal replacement therapy (RRT) for end-stage disease (ESRD) due to multiple myeloma (MM) or light-chain deposit (LCDD) is scarce. The aim this study was describe the incidence, characteristics, causes death rates RRT ESRD MM LCDD in ERA-EDTA Registry.
Background. The use of plasma exchange (PE) for induction treatment anti-neutrophil cytoplasm autoantibody (ANCA)-associated vasculitis (AAV), including Wegener's granulomatosis (WG), is still controversial. PE in AAV not commonly accepted patients with a creatinine <500 μmol/L (5.7 mg/dL) despite experimental support involvement ANCA the pathogenesis vasculitis. Methods. In single-centre study from tertiary referral centre, 32 ANCA-positive WG were treated standard immunosuppressive...
Epidemiological studies consistently show an initial survival advantage for PD patients compared to HD. It has recently been suggested that this is due the fact many HD are referred late, and start dialysis on acute, in-patient basis. The present study was performed investigate (1) whether, if so, how, prognosis had changed in recent years, (2) whether a potential of versus constant over duration, (3) differences could be explained by patient age, renal diagnosis diabetic nephropathy, or...
Although arteriovenous fistulas (AVFs) are actively promoted, their use at the start of haemodialysis (HD) seems to be decreasing worldwide. In this paper, we describe recent trends in incidence and prevalence vascular access types Europe from 2005 2009 relationship with patient characteristics survival. Ten European renal registries participating ERA-EDTA Registry provided data on (n = 13 044) and/or 75 715) types. We used logistic regression assess which factors influence likelihood...
In recent years, increased efforts have been undertaken to address the needs of patients with rare diseases by international initiatives and consortia devoted disease research management. However, information on overall prevalence within end-stage renal (ESRD) population is limited. The aims this study were (i) identify those ERA-EDTA Registry for which replacement therapy (RRT) being provided (ii) determine incidence RRT ESRD due diseases, both separately children adults.The Orphanet...